Clinical Trial Update: A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma [Phase 1]

View source ↗

Summary

This document reports Phase 1 results from a trial in relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. The study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Hodgkin Lymphoma

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Hodgkin Lymphoma, Anaplastic Large-cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2016-02-09